Singh, K., Rubenstein, K., Callier, V., Shaw-Saliba, K., Rupert, A., Dewar, R. L., Laverdure, S., Highbarger, H., Lallemand, P., Huang, M., Jerome, K. R., Sampoleo, R., Mills, M., Porter, D. P., Juneja, K., Greninger, A. L., Clifford Lane, H., Beigel, J. H., Dodd, L. E., & Dodd, L. E. (n.d.). 789. Viral and Immunologic biomarkers of COVID-19 improve risk stratification and identify patients most likely to benefit from therapy with remdesivir. Open forum infectious diseases, 9, . http://access.bl.uk/ark:/81055/vdc_100174899139.0x000014